Insider · CIK 0001679440

Friedberg Ezra M

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001679440

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−558 sh	$20.72	−$11.6K	80,484
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−534 sh	$26.03	−$13.9K	81,066
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−24 sh	$27.33	−$655.81	81,042
2026-06-15	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−224 sh	$27.12	−$6,075.888	81,659
2026-06-15	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−59 sh	$27.94	−$1,648.478	81,600
2026-05-14	PTHSPelthos Therapeutics Inc.F Tax Payment	Director	FTax Payment	−144 sh	$27.01	−$3,889.008	81,883
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−293 sh	$20.51	−$6,010.045	82,292
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−265 sh	$21.36	−$5,660.718	82,027
2025-11-25	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−5,999 sh	$28.00	−$168K	34,001
2025-11-25	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−2,000 sh	$28.14	−$56.3K	32,001
2025-11-25	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−1 sh	$28.50	−$28.5	32,000
2025-11-25	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−2,000 sh	$28.00	−$56K	30,000
2025-07-02	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.1K sh	—	—	28,012
2025-07-02	PTHSPelthos Therapeutics Inc. · Stock OptionA Award	Director	AAward	+58.2K sh	—	—	58,230
2025-07-02	PTHSPelthos Therapeutics Inc.A Award	Director	AAward	+19.1K sh	—	—	82,585
2025-07-01	PTHSPelthos Therapeutics Inc.C Conversion	Director	CConversion	+40K sh	$10.00	+$400K	40,000
2025-07-01	PTHSPelthos Therapeutics Inc.C Conversion	Director	CConversion	+40K sh	$10.00	+$400K	40,000
2025-07-01	PTHSPelthos Therapeutics Inc. · Series A Convertible Preferred StockP Purchase	Director	PPurchase	+40K sh	—	—	40,000
2025-07-01	PTHSPelthos Therapeutics Inc. · Series A Convertible Preferred StockP Purchase	Director	PPurchase	+40K sh	—	—	40,000
2025-07-01	PTHSPelthos Therapeutics Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−40K sh	—	—	0
2025-07-01	PTHSPelthos Therapeutics Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−40K sh	—	—	0
2024-11-13	PTHSPelthos Therapeutics Inc.A Award	Director	AAward	+2,454 sh	—	—	63,477
2024-06-14	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsA Award	Director	AAward	+64.5K sh	—	—	610,219
2024-06-14	PTHSPelthos Therapeutics Inc.A Award	Director	AAward	+6,450 sh	—	—	61,023
2024-02-21	PTHSPelthos Therapeutics Inc.P Purchase	Director	PPurchase	+16.7K sh	$6.00	+$100K	545,721
2024-02-21	PTHSPelthos Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.6K sh	$4.80	+$65.5K	513,727
2024-02-21	PTHSPelthos Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,992 sh	$4.80	+$33.6K	520,719
2024-02-21	PTHSPelthos Therapeutics Inc. · Secured Convertible Promissory NoteC Conversion	Director	CConversion	−65.5K sh	—	—	0
2024-02-21	PTHSPelthos Therapeutics Inc. · Secured Convertible Promissory NoteC Conversion	Director	CConversion	−33.1K sh	—	—	0
2016-09-13	HUMANIGEN, INCStock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Oct 64
Friedberg Ezra M0001919246-26-000130
SEC(opens sec.gov)
Jul 74
Friedberg Ezra M0001919246-26-000102
SEC(opens sec.gov)
Jun 174
Friedberg Ezra M0001919246-26-000093
SEC(opens sec.gov)
May 184
Friedberg Ezra M0001919246-26-000073
SEC(opens sec.gov)
Apr 64
Friedberg Ezra M0001919246-26-000054
SEC(opens sec.gov)
Apr 14/A
Friedberg Ezra M0001919246-26-000047
SEC(opens sec.gov)
Nov 264
Friedberg Ezra M0001753926-25-001831
SEC(opens sec.gov)
Jul 74
Friedberg Ezra M0001753926-25-001104
SEC(opens sec.gov)
Jul 34
Friedberg Ezra M0001753926-25-001079
SEC(opens sec.gov)

Companies

Address

C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110

DURHAM, NC, 27703